Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AGIO Agios Pharmaceuticals, Inc.

盘前交易 07-23 07:26:43 EDT

47.75

+1.14

+2.45%

最高47.76	最低46.15	成交量41.71万
今开46.86	昨收46.61	日振幅3.45%
总市值27.11亿	流通市值22.62亿	总股本5,677万
成交额1,972万	换手率0.88%	流通股本4,737万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals, Inc.","latestPrice":47.75,"timestamp":1721678400000,"preClose":46.61,"halted":0,"volume":417076,"delay":0,"floatShares":47370511,"shares":56772966,"eps":-6.304535,"marketStatus":"盘前交易","marketStatusCode":1,"change":1.14,"latestTime":"07-23 07:26:43 EDT","open":46.86,"high":47.76,"low":46.15,"amount":19723134.491016,"amplitude":0.034542,"askPrice":52.98,"askSize":100,"bidPrice":47.1,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-6.304535,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721741400000},"adr":0,"listingDate":1374638400000,"adjPreClose":47.75,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":47.75,"preClose":47.75,"latestTime":"16:26 EDT","volume":18892,"amount":902098.76,"timestamp":1721680012162},"volumeRatio":0.6146408779348542,"impliedVol":0.5257,"impliedVolPercentile":0.6096},"requestUrl":"/m/hq/s/AGIO","defaultTab":"news","newsList":[{"id":"2450368039","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450368039","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450368039?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:45","pubTimestamp":1720705549,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时45分，Agios Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.04%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Biodexa Pharmaceuticals Plc、Virpax Pharmaceuticals, Inc.、Terns Pharmaceuticals, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Salarius Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为436.57%、269.99%、185.87%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Anew Medical Inc C/Wts 21/06/2029 、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为64.69%、39.71%、28.57%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214549aef93d90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214549aef93d90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2443548601","title":"Agios Pharmaceuticals, Inc.盘中异动 大幅跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443548601","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443548601?lang=zh_cn&edition=full","pubTime":"2024-06-15 02:40","pubTimestamp":1718390436,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日02时40分，Agios Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.02%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Nkgen Biotech Inc C/Wts 31/05/2028、Tracon Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Longeveron Inc.、Bio-Path Holdings, Inc.较为活跃，换手率分别为2318.22%、1418.49%、267.20%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为129.28%、67.98%、60.25%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615024037968145d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615024037968145d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2440237104","title":"Agios Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440237104","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440237104?lang=zh_cn&edition=full","pubTime":"2024-06-04 23:26","pubTimestamp":1717514769,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日23时26分，Agios Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.11%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。消息层面，截至23时26分，《加皇资本市场维持Agios Pharmaceuticals买入评级，上调目标价至53美元》资讯为影响Agios Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604232609aef35800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604232609aef35800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2440547009","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440547009","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440547009?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":"    路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻             * Brixmor Property Group Inc   ：高盛将该公司列入其在美上市公司信用评级名单              * 霍尼韦尔国际公司  ：加拿大皇家银行将目标价从222美元下调至218美元              * 西蒙地产集团  ：高盛将其股票从美国定罪名单中删除              * Stericycle Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","BK4539","BK4082","BK4187","BWMN","HHH","SRCL","TGT","HUM","SGC","S","CLSK","LU1621768115.EUR","BK4088","LU2286300806.USD","GPCR","BK4155","LU1621767810.EUR","CMCO","AGIO","HON","SPG","GTLB","BK4154","BA","SG9999014013.SGD","BK4532","SRE","ENPH","LU0823414478.USD","SO","EW","IE00BMG7P587.USD","GMAB","ZS","QCOM","LU1267930227.SGD","BRX","TOL","FWONK","BK4080","MARA","FSLR","EQT","TER","LU1621767737.EUR","IE00BMG7P694.USD","RIOT"],"gpt_icon":0},{"id":"2440470047","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440470047","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440470047?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":"    路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻             * Brixmor Property Group Inc   ：高盛将该公司列入其在美上市公司信用评级名单              * 霍尼韦尔国际公司  ：加拿大皇家银行将目标价从222美元下调至218美元              * 西蒙地产集团  ：高盛将其股票从美国定罪名单中删除              * Stericycle Inc   ：加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","MARA","HON","IE00BMG7P587.USD","SPG","BK4080","BK4155","GMAB","SG9999014013.SGD","QCOM","SRCL","LU1267930227.SGD","LU2286300806.USD","LU1621768115.EUR","BRX","LU1621767737.EUR","EQT","BK4088","ZS","BA","TOL","CLSK","BK4532","LU0823414478.USD","TER","LU1621767810.EUR","SGC","BWMN","ARWR","BK4154","AGIO","HUM","SO","ENPH","BK4082","GTLB","BK4187","FWONK","CMCO","BK4539","IE00BMG7P694.USD","S","RIOT","SRE","EW","HHH","FSLR","TGT"],"gpt_icon":0},{"id":"2440495825","title":"Agios Pharmaceuticals, Inc.盘中异动 快速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440495825","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440495825?lang=zh_cn&edition=full","pubTime":"2024-06-03 21:34","pubTimestamp":1717421670,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日21时34分，Agios Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.12%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Bio-Path Holdings, Inc.、Biocardia Inc C/Wts 06/08/2024涨幅较大，Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1545.39%、41.37%、18.78%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Kintara Therapeutics, Inc.，振幅分别为31.55%、24.17%、23.20%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213430968117fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603213430968117fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2440463772","title":"Agios 制药公司的血液病药物在后期研究中获得成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2440463772","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440463772?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:35","pubTimestamp":1717410930,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透6月3日 - Agios Pharmaceuticals   公司周一表示，其治疗一种遗传性血液疾病的实验性疗法在一项后期研究中达到了主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2439590147","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590147","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590147?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":"    路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括欧特克、麦科森和微策略。要闻  * 模拟器件公司  ：雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc   ：贝尔德将目标价从296美元下调至289美元 * Cencora Inc   ：贝雅将目标价从277美元上调至280美元 * McKesson Corp   ：贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc   ：Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","MNMD","TAP","CAVA","LU0310799852.SGD","ADI","MCK","LU1642822529.SGD","CASY","CTRE","INSM","BK4139","AGIO","MNRO","NAPA","PDFS","AAL","MSTR","CAH","BAH","BK4528","SAGE","AKTS","BK4529","DOMO","LU0006061336.USD","MYRG","BK4585","TGI","CRVO","UAL","RLJ","LU0323240290.USD","HRT","BK4214","BK4561","IBTX","ADSK","RSI","LYV","STZ","TKO","LU1978683503.SGD","PLMR","LU1244550221.USD","COR","IE00B7SZL793.SGD","IKNA","BK4588","BK4130"],"gpt_icon":0},{"id":"2439590142","title":"美国研究综述-欧特克、McKesson、Microstrategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2439590142","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439590142?lang=zh_cn&edition=full","pubTime":"2024-05-29 15:12","pubTimestamp":1716966778,"startTime":"0","endTime":"0","summary":"    路透5月29日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括欧特克、麦科森和微策略。要闻  * 模拟器件公司  ：雷蒙德-詹姆斯将目标价从215美元上调至260美元 * Autodesk Inc   ：贝尔德将目标价从296美元下调至289美元 * Cencora Inc   ：贝雅将目标价从277美元上调至280美元 * McKesson Corp   ：贝尔德将目标价从671美元上调至679美元 * Microstrategy Inc   ：Canaccord Genuity将目标价从1,590美元上调至2,047美元 以下是路透周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSI","IBTX","NAPA","TAP","ADI","PDFS","LU0323240290.USD","DOMO","SAGE","CASY","LU1978683503.SGD","BK4561","CTRE","BAH","RLJ","BK4214","HRT","MCK","AGIO","STZ","LU0006061336.USD","INSM","TGI","BK4588","COR","IE00B19Z4B17.USD","LU1642822529.SGD","BK4529","LYV","BK4130","MNMD","AKTS","MYRG","BK4528","CAH","MNRO","BK4139","ADSK","BK4585","CAVA","PLMR","MSTR","AAL","TKO","IKNA","LU0310799852.SGD","LU1244550221.USD","CRVO","IE00B7SZL793.SGD","UAL"],"gpt_icon":0},{"id":"2438374075","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大涨21.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438374075","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438374075?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:32","pubTimestamp":1716903122,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时32分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅拉升21.44%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Exicure, Inc.涨幅较大，Exicure, Inc.、Nls Pharmaceutics Ltd.、Jaguar Health, Inc.较为活跃，换手率分别为18.89%、7.41%、7.09%，振幅较大的相关个股有Exicure, Inc.、Corcept医疗、Sensei Biotherapeutics, Inc.，振幅分别为20.73%、13.15%、10.20%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213202956f167f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213202956f167f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2438751153","title":"BUZZ-与 Royalty Pharma 达成 9.05 亿美元脑肿瘤治疗协议，Agios 公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2438751153","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438751153?lang=zh_cn&edition=full","pubTime":"2024-05-28 20:20","pubTimestamp":1716898843,"startTime":"0","endTime":"0","summary":"    5月28日 - ** 药物开发商Agios Pharmaceuticals   股价盘前上涨22.2%至38.50美元** 法国药物开发商Servier的脑肿瘤治疗药物vorasidenib获得FDA批准后，该公司将获得11亿美元的付款** 公司计划在美国 FDA 批准 vorasidenib 后，以 9.05 亿美元的预付款将其在美国潜在净销售额中 15% 的版税权出售给 Royalty Pharma    公司， 。** RPRX 从学术实验室和生物技术公司购买未来药物的特许权使用费，这些实验室和生物技术公司用这笔现金资助研究。** AGIO 将保留该疗法在美国年净销售额超过 10 亿美元的 3% 的特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139","BK4007","RPRX","BUZZ"],"gpt_icon":0},{"id":"2438729064","title":"Agios Pharmaceuticals, Inc.盘中异动 大幅跳水5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438729064","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438729064?lang=zh_cn&edition=full","pubTime":"2024-05-25 02:45","pubTimestamp":1716576303,"startTime":"0","endTime":"0","summary":"北京时间2024年05月25日02时45分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.17%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Merus N.V.涨幅较大，Onconetix, Inc.、Verastem, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为156.90%、66.95%、37.24%，振幅较大的相关个股有Onconetix, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cns Pharmaceuticals, Inc.，振幅分别为104.53%、57.38%、55.25%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405250245039680fab1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405250245039680fab1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2434502869","title":"Agios Pharmaceuticals, Inc.2024财年第一财季实现净利润-81.55百万美元，同比减少0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434502869","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434502869?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:19","pubTimestamp":1715357945,"startTime":"0","endTime":"0","summary":"3月31日，Agios Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-81.55百万美元，同比减少0.65%；其中营业收入为8.19百万美元，同比增加45.99%，每股基本收益为-1.45美元。机构评级：截至2024年3月31日，当前有6家机构对Agios Pharmaceuticals, Inc.目标价做出预测，其中目标均价为41.67美元，其中最低目标价为30.00美元，最高目标价为49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019128af1a7a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110019128af1a7a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO"],"gpt_icon":0},{"id":"2432935222","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432935222","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432935222?lang=zh_cn&edition=full","pubTime":"2024-05-03 01:34","pubTimestamp":1714671295,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日01时34分，Agios Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.02%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Effector Therapeutics Inc C/Wts 31/12/2025 、Sensei Biotherapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为4436.56%、676.13%、153.78%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为160.58%、78.82%、49.56%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503013455861eab93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503013455861eab93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2432985868","title":"Agios 制药公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432985868","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432985868?lang=zh_cn&edition=full","pubTime":"2024-05-02 23:08","pubTimestamp":1714662497,"startTime":"0","endTime":"0","summary":"   * Agios Pharmaceuticals Inc   报告了截至3月底的季度调整后每股亏损1.45美元，高于去年同期的每股亏损1.47美元。9位分析师对该季度的平均预期是每股亏损1.65美元。华尔街预期为每股亏损 1.78 美元至 1.53 美元。* 营收同比增长 46%，达到 819 万美元；分析师预期为 837 万美元。* Agios Pharmaceuticals Inc公布的本季度每股收益为亏损1.45美元。* 该公司一季度亏损 8155 万美元。* Agios Pharmaceuticals Inc 的股价本季度上涨了 15.1%，今年迄今为止上涨了 51.1%。华尔街对 Agios Pharmaceuticals Inc 的 12 个月目标价中位数为 45.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2432663366","title":"Agios Pharmaceuticals, Inc.盘中异动 急速上涨5.08%报34.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432663366","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432663366?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:47","pubTimestamp":1714589260,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时47分，Agios Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.08%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.93%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Bioatla, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1407.75%、1167.98%、262.29%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020247407925a4c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020247407925a4c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2431327730","title":"Agios Pharmaceuticals Inc    预计每股亏损 1.65 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431327730","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431327730?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:36","pubTimestamp":1714487800,"startTime":"0","endTime":"0","summary":"   * Agios Pharmaceuticals Inc    将于5月2日公布截至2024年3月31日的财报，预计季度收入将有所增长。* LSEG 分析师对 Agios Pharmaceuticals Inc 的平均预期是每股亏损 1.65 美元。* 华尔街对 Agios Pharmaceuticals Inc 的 12 个月目标价中位数为 45.00 美元，高于其上次收盘价 32.76 美元。4月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"gpt_icon":0},{"id":"2429114352","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报31.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429114352","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429114352?lang=zh_cn&edition=full","pubTime":"2024-04-24 01:08","pubTimestamp":1713892085,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日01时08分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.00%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为2608.87%、180.30%、50.88%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Palisade Bio, Inc.，振幅分别为80.08%、56.09%、45.43%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240108057922b712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240108057922b712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2427759030","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427759030","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427759030?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:40","pubTimestamp":1712947253,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时40分，Agios Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.16%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3675.52%、1450.47%、102.76%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、73.57%、58.59%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413024054861e55f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240413024054861e55f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2426811386","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426811386","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426811386?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:27","pubTimestamp":1712672823,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时27分，Agios Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.42%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。该信息摘要如下：坎托菲茨杰拉德公司：重申Agios Pharmaceuticals增持评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040922270487e7ee45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040922270487e7ee45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":0.0559},{"period":"3month","weight":0.5011},{"period":"6month","weight":1.2199},{"period":"1year","weight":0.7351},{"period":"ytd","weight":1.1441}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司，致力于通过细胞代谢领域的领导地位改变患者的生活，目标是为罕见病创造差异化药物，重点是经典血液学。","yearOnYearQuotes":[{"month":1,"riseRate":0.818182,"avgChangeRate":0.042769},{"month":2,"riseRate":0.636364,"avgChangeRate":0.059258},{"month":3,"riseRate":0.545455,"avgChangeRate":0.003251},{"month":4,"riseRate":0.545455,"avgChangeRate":0.006144},{"month":5,"riseRate":0.545455,"avgChangeRate":0.049654},{"month":6,"riseRate":0.636364,"avgChangeRate":0.046688},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.021368},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.049224},{"month":9,"riseRate":0.545455,"avgChangeRate":0.047807},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.015381},{"month":11,"riseRate":0.636364,"avgChangeRate":0.038309},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.013921}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals, Inc.","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Agios Pharmaceuticals, Inc.,AGIO,Agios Pharmaceuticals, Inc.股票,Agios Pharmaceuticals, Inc.股票老虎,Agios Pharmaceuticals, Inc.股票老虎国际,Agios Pharmaceuticals, Inc.行情,Agios Pharmaceuticals, Inc.股票行情,Agios Pharmaceuticals, Inc.股价,Agios Pharmaceuticals, Inc.股市,Agios Pharmaceuticals, Inc.股票价格,Agios Pharmaceuticals, Inc.股票交易,Agios Pharmaceuticals, Inc.股票购买,Agios Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}